Iomeprol
Overview
Iomeprol is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2107214).
API suppliers (2)
Suppliers of Iomeprol evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
- SUZHOU RYWAY BIOTECH CO LTD1 active DMF
- BRACCO IND CHIMICA SPA
Patent & exclusivity (US)
Per the FDA Orange Book (8 approved US products), the latest listed US patent on Iomeprol expires — and exclusivity 27 Nov 2029. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 1-N,3-N-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-methylamino]-2,4,6-triiodobenzene-1,3-dicarboxamide
- Canonical SMILES
- CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
- InChIKey
- NJKDOADNQSYQEV-UHFFFAOYSA-N
Do you supply Iomeprol? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.